Article Versions Notes

Frezzato F, Visentin A, Severin F, Pizzo S, Ruggeri E, Mouawad N, Martinello L, Pagnin E, Trimarco V, Tonini A, et al. Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers. 2021; 13(21):5453. https://doi.org/10.3390/cancers13215453

Frezzato, Federica, Andrea Visentin, Filippo Severin, Serena Pizzo, Edoardo Ruggeri, Nayla Mouawad, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Alessia Tonini, and et al. 2021. "Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia" Cancers 13, no. 21: 5453. https://doi.org/10.3390/cancers13215453

Frezzato, F., Visentin, A., Severin, F., Pizzo, S., Ruggeri, E., Mouawad, N., Martinello, L., Pagnin, E., Trimarco, V., Tonini, A., Carraro, S., Pravato, S., Imbergamo, S., Manni, S., Piazza, F., Brunati, A. M., Facco, M., & Trentin, L. (2021). Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers, 13(21), 5453. https://doi.org/10.3390/cancers13215453